Real-life multicenter experience of long-term treatment with venetoclax plus azacitidine for acute myeloid leukemia in China.

Sci Rep · 2026 · PMC13280151 · PMID 42032126

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Patients with NPM1 and IDH2 mutations were associated with improved OS, although the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.